Barron's on MSN: This startup’s psoriasis drug studies have lifted its stock Yahoo: J&J's oral psoriasis drug helps patients achieve clear skin in late-stage study J&J's oral psoriasis drug helps patients achieve clear skin in late-stage study Johnson & Johnson failed to prove that the launch of a biosimilar version to its psoriasis drug Stelara will harm the company’s business, a federal appeals court ruled Tuesday. Johnson & Johnson exceeded first-quarter earnings forecasts, driven by high demand for its cancer drug Darzalex and psoriasis treatment Tremfya, outweighing declines in Stelara sales. The company's ...

Understanding the Context

AOL: FDA approved psoriasis drug could prevent Type 1 diabetes, study finds INDIANAPOLIS (WISH) — A drug already approved by the U.S. Food and Drug Administration to treat psoriasis could offer new hope for people with Type 1 diabetes, according to a new study co-led by ... If a person has moderate or severe psoriasis and a doctor believes drug therapy is medically necessary, Medicare can generally help cover the cost. Possible covered medications include prescription ...

Key Insights